Cardiovascular/Pain Specialty position

Discussion in 'Daiichi-Sankyo' started by anonymous, Apr 27, 2017 at 10:50 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Interviewing for a Cardiovascular/Pain specialty position...how are things going with Movantik, Welchol & Savaysa? Good company? Good bonus structure? Asking for a friend...
     

  2. anonymous

    anonymous Guest

    Savaysa is dead in the water will only be promoted for a little longer. How does one discover a drug class and hit the market dead last? Top that off with almost non existent managed care. Did they really advertise a position as cardiovascular if so that is a joke! If you are looking for a company with crappy products, crappy pipeline and love to be micromanaged DSI is for you. Most reps are looking to leave this joke of a company.
     
  3. anonymous

    anonymous Guest

    Savaysa is dead. Movantik is a decent drug however the expectations and goals are set way too high. A year ago nation grew by 10%. They expect 40% growth this year. You will never hit target payout unless you lie cheat and steal like the NY area. Even those reps that hit 100% growth will gross 13k payout.